Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Boehringer Ingelheim
McKesson
Medtronic
AstraZeneca

Last Updated: December 1, 2022

Dopamine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for dopamine hydrochloride and what is the scope of freedom to operate?

Dopamine hydrochloride is the generic ingredient in six branded drugs marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for dopamine hydrochloride. Eight suppliers are listed for this compound.

Summary for dopamine hydrochloride
Recent Clinical Trials for dopamine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nantes University HospitalPhase 3
Region SkanePhase 3
Lund UniversityPhase 3

See all dopamine hydrochloride clinical trials

Pharmacology for dopamine hydrochloride
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for dopamine hydrochloride

US Patents and Regulatory Information for dopamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018138-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018132-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hikma Intl Pharms DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 207707-002 Apr 11, 2018 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Johnson and Johnson
Colorcon
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.